Financials

  • Market Capitalization 1.28 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.74
市销率
941.13

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2218
ANAB
AnaptysBio, Inc. - Common Stock
45.59 USD-0.98%-4.80%-16.46%+29.52%1.33 B USD
2227
NKTR
Nektar Therapeutics - Common Stock
37.91 USD-4.84%-5.01%-45.84%-48.26%1.29 B USD
2264
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
13.95 USD-15.71%-19.69%-23.60%-7.00%1.25 B USD
2267
DRTS
Alpha Tau Medical Ltd. - Ordinary Shares
13.74 USD-3.65%-5.11%-2.62%+251.41%1.21 B USD

新闻